|Application:||Gene expression microarray analysis|
|Number of samples:||14|
|Release date:||Mar 17 2012|
|Last update date:||Feb 22 2018|
|Diseases:||Neoplasms, Prostatic Neoplasms|
|Dataset link||Expression correlates of the full-length androgen receptor and its splicing variants|
LNCaP cells lacking AR-V were transfected with AR-V7 with or without androgen stimulation of AR-FL (4 conditions); LNCaP95 cells expressing AR-Vs were treated with control siRNA or siRNA trageting AR-LBD or AR-DBD, with or without androgen stimulation of AR-FL (6 conditions); VCaP cells expressing AR-Vs in the presence of androgen were treated with control siRNA, siRNA trageting AR-LBD, DMSO or MDV3100 to inhibit AR-FL (4 conditions). Total 14 arrays with no replicates.